VC-backed scPharmaceuticals rakes in almost $90 mln for IPO
Burlington, Massachusetts-based scPharmaceuticals Inc, a biopharmaceutical company that is developing drugs for subcutaneous delivery, has raised $89.6 million for its IPO after pricing its 6.4 million shares at $14 per share. The stock began trading November 17, 2017 on the NASDAQ under the ticker symbol "SCPH." Jefferies, Leerink Partners and BMO Capital Markets are the lead underwriters. The company's pre-IPO backers include OrbiMed, 5AM Ventures and Lundbeckfond Ventures.
17 November 2017•2 mins read
